Eton Pharmaceuticals, Inc. (ETON)
61.27
-0.09
(-0.15%)
USD |
NASDAQ |
Nov 20, 14:13
Eton Pharmaceuticals Net Income (Quarterly) : 35.25M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 35.25M |
| June 30, 2026 | 11.58M |
| March 31, 2026 | 1.554M |
| December 31, 2025 | 1.483M |
| September 30, 2025 | -1.927M |
| June 30, 2025 | -2.585M |
| March 31, 2025 | -1.572M |
| December 31, 2024 | -0.598M |
| September 30, 2024 | 0.627M |
| June 30, 2024 | -3.041M |
| March 31, 2024 | -0.811M |
| December 31, 2023 | -2.256M |
| September 30, 2023 | -0.579M |
| June 30, 2023 | 4.559M |
| March 31, 2023 | -2.66M |
| December 31, 2022 | 0.912M |
| September 30, 2022 | -3.045M |
| June 30, 2022 | -1.558M |
| March 31, 2022 | -5.33M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.039M |
| September 30, 2021 | -6.094M |
| June 30, 2021 | -2.016M |
| March 31, 2021 | 5.116M |
| December 31, 2020 | -7.687M |
| September 30, 2020 | -6.504M |
| June 30, 2020 | -4.73M |
| March 31, 2020 | -9.049M |
| December 31, 2019 | -2.696M |
| September 30, 2019 | -4.965M |
| June 30, 2019 | -3.249M |
| March 31, 2019 | -7.41M |
| December 31, 2018 | -3.73M |
| September 30, 2018 | -2.91M |
| June 30, 2018 | -3.082M |
| March 31, 2018 | -3.018M |
| December 31, 2017 | -2.17M |
| September 30, 2017 | -2.802M |
| June 30, 2017 | -2.184M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Aquestive Therapeutics, Inc. | -16.50M |
| Pfizer Inc. | 3.251B |
| Amneal Pharmaceuticals, Inc. | 12.31M |
| ANI Pharmaceuticals, Inc. | 32.72M |
| Corcept Therapeutics, Inc. | 124.49M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 57.92M |
| Total Expenses (Quarterly) | 22.68M |
| EPS Diluted (Quarterly) | 1.060 |
| Enterprise Value | 1.738B |
| Gross Profit Margin (Quarterly) | 76.48% |
| Profit Margin (Quarterly) | 60.85% |
| Earnings Yield | 2.46% |
| Operating Earnings Yield | 2.06% |
| Normalized Earnings Yield | 2.464 |